Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
COMMENTARY
Free Access
free
Diagnosis and management of von Willebrand disease: A community-wide effort to deliver evidence-based clinical practice guidelines
- Pages: 181-183
- First Published: 09 February 2021
REVIEW ARTICLES
no
The role of total ankle replacement in patients with haemophilia and end-stage ankle arthropathy: A review
- Pages: 184-191
- First Published: 08 November 2020
Open Access
oa
Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?
- Pages: 192-198
- First Published: 27 February 2021
no
Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review
- Pages: 199-210
- First Published: 06 February 2021
no
Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders
- Pages: 211-220
- First Published: 06 February 2021
ORIGINAL ARTICLES
Clinical haemophilia
Open Access
oa
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors
- Pages: 221-228
- First Published: 28 January 2021
no
Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B
- Pages: 229-236
- First Published: 16 February 2021
no
Long-term joint outcomes of regular low-dose prophylaxis in Chinese children with severe haemophilia A
- Pages: 237-244
- First Published: 06 February 2021
Open Access
oa
Evidence of a disability paradox in patient-reported outcomes in haemophilia
- Pages: 245-252
- First Published: 17 February 2021
no
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data
- Pages: 253-260
- First Published: 17 February 2021
no
How to implement medical and patient associations in low-income countries: A proposition from the African French Alliance for the Treatment of Haemophilia (AFATH)
- Pages: 261-269
- First Published: 23 February 2021
Von Willebrand disease
no
Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures
- Pages: 270-276
- First Published: 06 February 2021
no
Incidence of von Willebrand disease in Denmark, 1995-2016: A cohort study
- Pages: 277-282
- First Published: 06 February 2021
Rare bleeding disorders
Open Access
oa
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency
- Pages: 283-292
- First Published: 16 December 2020
Women with bleeding disorders
Open Access
oa
Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review
- Pages: 293-304
- First Published: 24 December 2020
Muskuloskeletal
Open Access
oa
Shortening the paediatric Haemophilia Activities List (pedHAL) based on pooled data from international studies
- Pages: 305-313
- First Published: 16 February 2021
no
Functional and joint evaluation in a prospective cohort of patients with severe haemophilia
- Pages: 314-320
- First Published: 06 February 2021
Laboratory science
Open Access
oa
Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma
- Pages: 321-328
- First Published: 06 February 2021
REVIEW ARTICLE
no
Genetic causes of haemophilia in women and girls
- Pages: e164-e179
- First Published: 13 December 2020
ORIGINAL ARTICLES
Clinical haemophilia
no
Assessing the current knowledge, attitude and behaviour of adolescents and young adults living with haemophilia
- Pages: e180-e186
- First Published: 05 December 2020
no
Trends in coagulation factor replacement therapy and medical costs in patients with haemophilia in Taiwan: A population-based, 15-year analysis
- Pages: e187-e193
- First Published: 06 February 2021
Von Willebrand disease
no
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition
- Pages: e194-e203
- First Published: 08 February 2021
no
Variants p.Pro2063Ser and p.Arg324* co-segregate in type 3 von Willebrand disease patients from Southern Brazil
- Pages: e204-e213
- First Published: 06 February 2021
Laboratory science
Open Access
oa
Approximation of emicizumab plasma levels in emergency situations. A practical approach
- Pages: e214-e220
- First Published: 01 February 2021
Muskuloskeletal
no
Aquatic exercise in patients with haemophilia: Electromyographic and functional results from a prospective cohort study
- Pages: e221-e229
- First Published: 17 February 2021
no
The effects of manual therapy on musculoskeletal system, functional level, joint health and kinesiophobia in young adults with severe haemophilia: A randomized pilot study
- Pages: e230-e238
- First Published: 10 January 2021
no
Cementless total hip arthroplasty in haemophilia patients through direct anterior approach
- Pages: e239-e244
- First Published: 02 February 2021
no
Static postural balance evaluation and an investigation of the relationship with joint health in children with severe haemophilia: a controlled cross-sectional study
- Pages: e245-e252
- First Published: 24 January 2021
Open Access
oa
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study
- Pages: e253-e259
- First Published: 06 February 2021
Open Access
oa
Lower physical activity and altered body composition in patients with haemophilia compared with healthy controls
- Pages: e260-e266
- First Published: 12 February 2021
LETTERS TO THE EDITOR
no
Monitoring the joint health of patients with haemophilia in a middle-income country: Considerations on the use of the Haemophilia Joint Health Score
- Pages: e267-e269
- First Published: 08 September 2020
no
Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study
- Pages: e270-e273
- First Published: 08 September 2020
no
FVIII inhibitor risk correlated with F8 gene variants in 296 unrelated male Chinese patients with haemophilia A
- Pages: e274-e277
- First Published: 08 September 2020
no
Obstetrical bleeding in women with MYH9-related disease—A systematic review
- Pages: e278-e283
- First Published: 30 September 2020
no
Comprehensive care on paper only? The challenge for physiotherapy provision in day to day haemophilia practice
- Pages: e284-e286
- First Published: 04 October 2020
no
Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study
- Pages: e287-e290
- First Published: 30 September 2020
no
Combined intra-articular injections of hyaluronic acid and platelet-rich plasma for the treatment of haemophilic arthropathy: A case series study
- Pages: e291-e294
- First Published: 23 October 2020
no
Sports participation of patients with haemophilia in the COVID-19 era: The Dutch experience
- Pages: e295-e297
- First Published: 08 November 2020
no
Ultrasound and patient self-imaging in hemophilia
- Pages: e298-e301
- First Published: 25 November 2020
no
Addressing patient education priorities in the era of gene therapy for haemophilia: Towards evidence-informed shared decision-making
- Pages: e302-e304
- First Published: 27 November 2020